Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Best corrected visual acuity 0.1 LogMAR"
Page 1
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Cochrane Database Syst Rev. 2023 Jun 27;2023(6):CD007419. doi: 10.1002/14651858.CD007419.pub7.
Cochrane Database Syst Rev. 2023.
PMID: 38275741
Review.
In the previous update of this review, we found moderate-quality evidence that, at 12 months, aflibercept was slightly more effective than ranibizumab and bevacizumab for improving vision in people with DMO, although the difference may have been clinically insignificant (less tha …
In the previous update of this review, we found moderate-quality evidence that, at 12 months, aflibercept was slightly more effective than r …
Medical interventions for fungal keratitis.
FlorCruz NV, Evans JR.
FlorCruz NV, et al.
Cochrane Database Syst Rev. 2015 Apr 9;2015(4):CD004241. doi: 10.1002/14651858.CD004241.pub4.
Cochrane Database Syst Rev. 2015.
PMID: 25855311
Free PMC article.
Review.
The primary outcome was clinical cure at two to three months. Secondary outcomes included best-corrected visual acuity, time to clinical cure, compliance with treatment, adverse outcomes and quality of life. ...On average, people randomised to natamyci …
The primary outcome was clinical cure at two to three months. Secondary outcomes included best-corrected visual acui …
Item in Clipboard
Topical non-steroidal anti-inflammatory drugs for central serous chorioretinopathy: A systematic review and meta-analysis.
Larsson JME, Boberg-Ans LC, Vangsted A, van Dijk EHC, Grauslund J, Hajari JN, Klefter ON, Schneider M, Subhi Y.
Larsson JME, et al.
Acta Ophthalmol. 2024 May;102(3):274-284. doi: 10.1111/aos.15743. Epub 2023 Aug 8.
Acta Ophthalmol. 2024.
PMID: 37551858
Review.
Where specified, topical NSAIDs used were bromfenac 0.09%, diclofenac 0.1%, ketorolac 0.4% and 0.5%, pranoprofen 0.1%, and nepafenac 0.1% and 0.3%. ...Meta-analyses of comparative studies revealed a statistically significant but clinicall …
Where specified, topical NSAIDs used were bromfenac 0.09%, diclofenac 0.1%, ketorolac 0.4% and 0.5%, pranoprofen 0.1 …
Item in Clipboard
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.
Lim BX, Lim CH, Lim DK, Evans JR, Bunce C, Wormald R.
Lim BX, et al.
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
Cochrane Database Syst Rev. 2016.
PMID: 27801522
Free PMC article.
Review.
It may occur after cataract surgery and may give rise to poor visual outcome, with reduced visual acuity and distortion of the central vision. ...Results ranged from -30.9 m in favour of NSAIDs plus steroids to 7.44 m in favour of steroids alone. Similarly, d …
It may occur after cataract surgery and may give rise to poor visual outcome, with reduced visual acuity and distortion …
Item in Clipboard
Cite
Cite